Form 8-K - Current report:
SEC Accession No. 0001411690-25-000036
Filing Date
2025-03-31
Accepted
2025-03-31 16:03:50
Documents
17
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20250331.htm   iXBRL 8-K 31675
2 EX-99.1 bngopressrelease-20241231.htm EX-99.1 229315
6 picture1.jpg GRAPHIC 6865
7 picture3.jpg GRAPHIC 3015
8 picture4.jpg GRAPHIC 1947
  Complete submission text file 0001411690-25-000036.txt   428515

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20250331.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20250331_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20250331_pre.xml EX-101.PRE 13054
19 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20250331_htm.xml XML 2825
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25793059
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)